In NB, MYCN is a bona-fide oncogenic driver [1, 6–8] and it is known that the silencing of MYCN results in a decrease in cell proliferation and induction of cell differentiation in NB cells [9–11]. The gene discussed is MYCN; the disease is neuroblastoma.